A phase I study of chemo-radiotherapy with plerixafor for newly diagnosed glioblastoma (GB).

被引：7
|
作者：
Thomas, Reena Parada
Nagpal, Seema
Iv, Michael
Soltys, Scott G.
Corbin, Zachary
Xu, Linda Wei
Recht, Cathy Kahn
Bertrand, Sophie
Jain, Vani
Acevedo, Brenda
Brown, Martin
Recht, Lawrence David
机构：
[1] Stanford Univ Hosp, Stanford, CA 94305 USA
[2] Stanford Canc Ctr, Stanford, CA USA
[3] Stanford Canc Inst, Stanford, CA USA
[4] Stanford Univ, Stanford, CA 94305 USA
[5] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA
[6] Stanford Univ, Med Ctr, Palo Alto, CA 94304 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.2068
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2068
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Phase I study of afatinib and radiotherapy (RT) with or without temozolomide (TMZ) in newly diagnosed glioblastoma (GB).
    Saran, Frank
    Welsh, Liam
    James, Allan
    McBain, Catherine
    Gattamaneni, Rao
    Jefferies, Sarah
    Harris, Fiona
    Cseh, Agnieszka
    Pemberton, Karine
    Schaible, Jennifer
    Bender, Shaun
    Brada, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [2] A Comparison Between Chemo-Radiotherapy Combined With Immunotherapy and Chemo-Radiotherapy Alone for the Treatment of Newly Diagnosed Glioblastoma: A Systematic Review and Meta-Analysis
    Lara-Velazquez, Montserrat
    Shireman, Jack M.
    Lehrer, Eric J.
    Bowman, Kelsey M.
    Ruiz-Garcia, Henry
    Paukner, Mitchell J.
    Chappell, Richard J.
    Dey, Mahua
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [3] PHASE I STUDY OF VANDETANIB WITH RADIOTHERAPY AND TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA
    Drappatz, Jan
    Norden, Andrew D.
    Wong, Eric T.
    Doherty, Lisa M.
    LaFrankie, Debra C.
    Ciampa, Abigail
    Kesari, Santosh
    Sceppa, Christine
    Gerard, Mary
    Phan, Phuong
    Schiff, David
    Batchelor, Tracy T.
    Ligon, Keith L.
    Young, Geoffrey
    Muzikansky, Alona
    Weiss, Stephanie E.
    Wen, Patrick Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (01): : 85 - 90
  • [4] Impact of boost sequence in concurrent chemo-radiotherapy on newly diagnosed IDH-wildtype glioblastoma multiforme
    Kim, Nalee
    Lee, Jongyo
    Nam, Do-Hyun
    Lee, Jung-Il
    Seol, Ho Jun
    Kong, Doo-Sik
    Choi, Jung Won
    Chong, Kyuha
    Lee, Won Jae
    Chang, Jong Hee
    Kang, Seok-Gu
    Moon, Ju Hyung
    Cho, Jaeho
    Lim, Do Hoon
    Yoon, Hong In
    JOURNAL OF NEURO-ONCOLOGY, 2023, 165 (02) : 261 - 268
  • [5] Impact of boost sequence in concurrent chemo-radiotherapy on newly diagnosed IDH-wildtype glioblastoma multiforme
    Nalee Kim
    Joongyo Lee
    Do-Hyun Nam
    Jung-Il Lee
    Ho Jun Seol
    Doo-Sik Kong
    Jung Won Choi
    Kyuha Chong
    Won Jae Lee
    Jong Hee Chang
    Seok-Gu Kang
    Ju Hyung Moon
    Jaeho Cho
    Do Hoon Lim
    Hong In Yoon
    Journal of Neuro-Oncology, 2023, 165 : 261 - 268
  • [6] Correction to: Impact of boost sequence in concurrent chemo-radiotherapy on newly diagnosed IDH-wildtype glioblastoma multiforme
    Nalee Kim
    Joongyo Lee
    Do-Hyun Nam
    Jung-Il Lee
    Ho Jun Seol
    Doo-Sik Kong
    Jung Won Choi
    Kyuha Chong
    Won Jae Lee
    Jong Hee Chang
    Seok-Gu Kang
    Ju Hyung Moon
    Jaeho Cho
    Do Hoon Lim
    Hong In Yoon
    Journal of Neuro-Oncology, 2023, 165 : 269 - 269
  • [7] Phase I and pharmacodynamic study of arsenic trioxide plus radiotherapy for newly diagnosed glioblastoma
    Ryu, Samuel
    Ye, Xiaobu
    Olson, Jeffrey J.
    Mikkelsen, Tom
    Bangiyev, Lev
    Lesser, Glenn Jay
    Batchelor, Tracy
    Nabors, Louis B.
    Desideri, Serena
    Walbert, Tobias
    Grossman, Stuart A.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [8] Randomized, placebo-controlled, phase II study of dasatinib with standard chemo-radiotherapy for newly diagnosed glioblastoma (GBM), NCCTG N0877 (Alliance)
    Laack, Nadia N.
    Galanis, Evanthia
    Anderson, S. Keith
    Leinweber, Clinton
    Buckner, Jan C.
    Giannini, Caterina
    Geoffroy, Francois J.
    Johnson, Derek Richard
    Lesser, Glenn Jay
    Jaeckle, Kurt A.
    Sarkaria, Jann Nagina
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [9] Phase I Study of Adavosertib with Radiotherapy and Temozolomide in Newly Diagnosed Glioblastoma and Intratumoral Drug Levels in Recurrent Glioblastoma
    Lee, Eudocia Q.
    Alexander, Brian M.
    Romo, Carlos G.
    Supko, Jeffrey G.
    Agar, Nathalie Y. R.
    Talebi, Zahra
    Ahluwalia, Manmeet S.
    Desai, Arati S.
    Dietrich, Jorg
    Kaley, Thomas J.
    Peereboom, David M.
    Gantchev, Jennifer
    Baquer, Gerard
    Santagata, Sandro
    Takebe, Naoko
    Desideri, Serena
    Fisher, Joy D.
    Sims, Megan
    Ye, Xiaobu
    Ligon, Keith L.
    Nabors, Louis B.
    Grossman, Stuart A.
    Wen, Patrick Y.
    CLINICAL CANCER RESEARCH, 2025, 31 (06) : 983 - 992
  • [10] Phase I and pharmacodynamic study of arsenic trioxide plus radiotherapy in patients with newly diagnosed glioblastoma
    Ryu, Samuel
    Ye, Xiaobu
    Olson, Jeffrey J.
    Mikkelsen, Tom
    Bangiyev, Lev
    Lesser, Glenn J.
    Batchelor, Tracy
    Nabors, Burt
    Desideri, Serena
    Walbert, Tobias
    Grossman, Stuart A.
    NEURO-ONCOLOGY ADVANCES, 2024, 6 (01)
12345